Introduction Questionnaire design is a cornerstone of survey research. It guides the development of questions, structures the survey, and ensures it achieves the intended research objectives. Strong design enhances the validity and reliability of the data collected in...
The Role of a CRO in Medical Device Regulatory Compliance
Navigating FDA regulatory compliance for medical devices is a multifaceted challenge that demands precision, expertise, and seamless collaboration. For medical device regulatory consultants and compliance-focused professionals, partnering with a specialized Contract...
FAQs about the FDA’s Final Rule on ACNU for Nonprescription Drugs
What is ACNU? ACNU stands for "Additional Condition for Nonprescription Use," a regulatory framework introduced by the U.S. Food and Drug Administration (FDA) to make certain medications available over-the-counter (OTC) while ensuring they are safe and effective for...
What to Know About FDA’s Self-Selection Studies Guidance
FDA self-selection studies are critical to the regulatory evaluation process, particularly for over-the-counter (OTC) drugs and direct-to-consumer (DTC) medical devices. These studies evaluate whether typical users can accurately choose if a health product is right...
Understanding LDTs with Real-World Examples
Laboratory Developed Tests (LDTs) have become an essential part of healthcare diagnostics. These specialized tests, developed and processed within CLIA-certified laboratories, offer customized solutions that help close diagnostic gaps left by commercial options. They are particularly important in areas where traditional diagnostics fall short, such as personalized healthcare.
Advancing LGBTQIA+ Representation: The FDA’s Role in Inclusive Diversity in Clinical Trials
Inclusive clinical trials are essential for ensuring that new treatments and medical interventions benefit all populations, particularly those historically underrepresented in research. By addressing barriers such as non-inclusive screening processes and lack of awareness in LGBTQIA+ communities, the FDA is making strides toward more diverse and representative clinical trial cohorts. This commitment to inclusivity will help create safer, more effective treatments that reflect the needs of all individuals, regardless of gender identity or sexual orientation.
Understanding Response Rate vs. Completion Rate: What’s the Difference?
This article will explain the difference between response rate and completion rate, why each matters, and how both can impact the overall data quality of your survey.
How Patient Preferences Shape Medical Device Development: Insights from FDA Draft Guidance
Explore how Patient Preference Information (PPI) impacts medical device development and regulatory submissions, with insights from the FDA’s draft guidance and key benefits for manufacturers.
Campus Climate Survey Examples in Higher Education: Case Studies and Outcomes
Ensuring a positive campus experience for all students requires understanding each university’s campus climate – an essential part of guaranteeing a school’s sustainability for faculty and students alike. A campus climate survey is an excellent resource designed to...